Black patients who have chronic liver failure, also known as end-stage liver disease, are less likely to be placed on a waiting list for a life-saving liver transplant than other racial and ethnic groups, according to a study.
When fall semester instruction begins online and in person Sept. 2, the 3,296 members of Cornell’s Class of 2024 just might be the most nimble group in the university’s history.
David Russell, the William Kaplan Professor of Infection Biology in the Department of Microbiology and Immunology, has been awarded a $2 million grant from the Mueller Health Foundation to develop new treatment regimens for tuberculosis.
Representing Cornell’s four contract colleges, the recipients of the 2021 State University of New York Chancellor’s Award for Student Excellence will be recognized during a virtual ceremony April 14.
According to a new study from researchers at Weill Cornell, COVID-19 may bring high risks of severe disease and death in many patients by disrupting key metabolic signals and thereby triggering hyperglycemia.
Poor function of the gene SMC3 can lead to improper immune cell development, and to cancer, by disrupting how DNA is structured inside the cell nucleus, according to new research from Weill Cornell Medicine.
Radiation therapy appears to increase the expression of genes with mutations that induce an immune response to malignant cells, according to preclinical research by Weill Cornell Medicine.
Shu-Bing Qian, a professor of molecular nutrition whose work explores how genetic information gets translated in order to make proteins in cells, has won a National Institutes of Health Director’s Pioneer Award.
New York Gov. Andrew M. Cuomo on March 24 announced the launch of the state’s free, online Citizen Public Health Training Course, delivered by the state Department of Health in partnership with Cornell.
Cornell COP26 delegation fueled the climate conversation in Glasgow, building new and unexpected connections to catalyze extraordinary change with support from Cornell Atkinson.